
Loading, please wait...

Loading, please wait...

Researchers analyzed 36,069 individuals with T1DM and 165,705 controls. Atrial fibrillation (AF) incidence declined in both groups. Adjusted AF risk was 1.34-fold higher in T1DM patients, but attenuated to 0.95 after accounting for cardiovascular comorbidities. Hemoglobin A1c, systolic blood pressure, BMI, and eGFR were independently associated with AF, highlighting the role of cardiometabolic factors in excess AF risk in T1DM patients.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


Researchers analyzed 36,069 individuals with T1DM and 165,705 controls. Atrial fibrillation (AF) incidence declined in both groups. Adjusted AF risk was 1.34-fold higher in T1DM patients, but attenuated to 0.95 after accounting for cardiovascular comorbidities. Hemoglobin A1c, systolic blood pressure, BMI, and eGFR were independently associated with AF, highlighting the role of cardiometabolic factors in excess AF risk in T1DM patients.
2 months ago

Discover the crucial role of glymphatic dysfunction in stroke, where perivascular clearance failure and neuroinflammation exacerbate cerebral edema and post-stroke brain injury.
Today

A prenatal case highlights severe glutaric acidemia type II presenting as bilateral hyperechoic cystic kidneys at 18 weeks. Whole-exome sequencing revealed a novel homozygous ETFDH frameshift variant, demonstrating the power of rapid genetic testing in fetal renal anomalies.
Today

Review how tailored exercise programs benefit frail older patients with heart failure. Explore pathophysiological mechanisms, individualized training prescriptions, and strategies to overcome adherence barriers in clinical practice.
Yesterday

This comparative study evaluates posterior labral tears with and without glenohumeral instability, highlighting distinct demographic patterns, MRI underestimation in stable shoulders, and successful arthroscopic repair outcomes.
Yesterday

A clinical study demonstrates that early intervention with tocilizumab, either as monotherapy or bridged with corticosteroids, achieves significant proptosis reduction and resolves active inflammation in treatment-naive thyroid eye disease.
Yesterday